Cargando…

α-Synuclein Toxicity in Drosophila melanogaster Is Enhanced by the Presence of Iron: Implications for Parkinson’s Disease

Parkinson’s disease (PD) is the second most common neurodegenerative disorder, characterized by the preferential loss of dopaminergic neurons and by the accumulation of intracellular inclusions mainly composed of α-synuclein (α-Syn). While the etiopathogenesis of the disorder is still elusive, recen...

Descripción completa

Detalles Bibliográficos
Autores principales:	Agostini, Francesco, Bubacco, Luigi, Chakrabarti, Sasanka, Bisaglia, Marco
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9952566/ https://www.ncbi.nlm.nih.gov/pubmed/36829820 http://dx.doi.org/10.3390/antiox12020261

Ejemplares similares

α-Synuclein overexpression increases dopamine toxicity in BE(2)-M17 cells
por: Bisaglia, Marco, et al.
Publicado: (2010)

Metformin Repurposing for Parkinson Disease Therapy: Opportunities and Challenges
por: Agostini, Francesco, et al.
Publicado: (2021)

DJ-1 and SOD1 Act Independently in the Protection against Anoxia in Drosophila melanogaster
por: De Lazzari, Federica, et al.
Publicado: (2022)

Leucine-rich repeat kinase 2 and alpha-synuclein: intersecting pathways in the pathogenesis of Parkinson's disease?
por: Greggio, Elisa, et al.
Publicado: (2011)

Oxidative Stress and Neuroinflammation in Parkinson’s Disease: The Role of Dopamine Oxidation Products
por: Chakrabarti, Sasanka, et al.
Publicado: (2023)

Copper Ions and Parkinson’s Disease: Why Is Homeostasis So Relevant?
por: Bisaglia, Marco, et al.
Publicado: (2020)

Antioxidant Therapy in Parkinson’s Disease: Insights from Drosophila melanogaster
por: De Lazzari, Federica, et al.
Publicado: (2020)

Alpha-synuclein, Proteotoxicity and Parkinson's Disease: Search for Neuroprotective Therapy
por: Ganguly, Upasana, et al.
Publicado: (2018)

Superoxide Dismutase (SOD)-mimetic M40403 Is Protective in Cell and Fly Models of Paraquat Toxicity: IMPLICATIONS FOR PARKINSON DISEASE
por: Filograna, Roberta, et al.
Publicado: (2016)

Impacts of increased α-synuclein on clathrin-mediated endocytosis at synapses: implications for neurodegenerative diseases
por: Medeiros, Audrey T., et al.
Publicado: (2018)

Parkinson’s disease and immune system: is the culprit LRRKing in the periphery?
por: Greggio, Elisa, et al.
Publicado: (2012)

Covalent α-Synuclein Dimers: Chemico-Physical and Aggregation Properties
por: Pivato, Micaela, et al.
Publicado: (2012)

Copper Binding and Redox Activity of α-Synuclein in Membrane-Like Environment
por: Bacchella, Chiara, et al.
Publicado: (2023)

Anti-Oxidants in Parkinson’s Disease Therapy: A Critical Point of View
por: Filograna, Roberta, et al.
Publicado: (2016)

DOPAL initiates αSynuclein-dependent impaired proteostasis and degeneration of neuronal projections in Parkinson’s disease
por: Masato, Anna, et al.
Publicado: (2023)

Human SOD2 Modification by Dopamine Quinones Affects Enzymatic Activity by Promoting Its Aggregation: Possible Implications for Parkinson’s Disease
por: Belluzzi, Elisa, et al.
Publicado: (2012)

Superoxide Radical Dismutation as New Therapeutic Strategy in Parkinson’s Disease
por: De Lazzari, Federica, et al.
Publicado: (2018)

Nuclear Factor-κB Dysregulation and α-Synuclein Pathology: Critical Interplay in the Pathogenesis of Parkinson’s Disease
por: Bellucci, Arianna, et al.
Publicado: (2020)

Iron Absorption in Drosophila melanogaster
por: Mandilaras, Konstantinos, et al.
Publicado: (2013)

Alpha-Synuclein as a Biomarker of Parkinson’s Disease: Good, but Not Good Enough
por: Ganguly, Upasana, et al.
Publicado: (2021)

Conformational Equilibria in Monomeric α-Synuclein at the Single-Molecule Level
por: Sandal, Massimo, et al.
Publicado: (2008)

Structural Features and Toxicity of α-Synuclein Oligomers Grown in the Presence of DOPAC
por: Palazzi, Luana, et al.
Publicado: (2021)

Small soluble α-synuclein aggregates are the toxic species in Parkinson’s disease
por: Emin, Derya, et al.
Publicado: (2022)

α-Synuclein impairs macroautophagy: implications for Parkinson’s disease
por: Winslow, Ashley R., et al.
Publicado: (2010)

The Convergence of Dopamine and α-Synuclein: Implications for Parkinson’s Disease
por: Mor, Danielle E, et al.
Publicado: (2018)

α-Synuclein impairs ferritinophagy in the retinal pigment epithelium: Implications for retinal iron dyshomeostasis in Parkinson’s disease
por: Baksi, Shounak, et al.
Publicado: (2017)

E46K mutant α-synuclein is more degradation resistant and exhibits greater toxic effects than wild-type α-synuclein in Drosophila models of Parkinson's disease
por: Sakai, Ryusuke, et al.
Publicado: (2019)

Triggering of Inflammasome by Aggregated α–Synuclein, an Inflammatory Response in Synucleinopathies
por: Codolo, Gaia, et al.
Publicado: (2013)

Inhibition of Ceramide Synthesis Reduces α-Synuclein Proteinopathy in a Cellular Model of Parkinson’s Disease
por: Mingione, Alessandra, et al.
Publicado: (2021)

GM1 Ganglioside Modifies α-Synuclein Toxicity and is Neuroprotective in a Rat α-Synuclein Model of Parkinson’s Disease
por: Schneider, Jay S., et al.
Publicado: (2019)

Toxicity of Dithiothreitol (DTT) to Drosophila melanogaster
por: Wang, Yiwen, et al.
Publicado: (2020)

Did α-Synuclein and Glucocerebrosidase Coevolve? Implications for Parkinson’s Disease
por: Gruschus, James M.
Publicado: (2015)

α-Synuclein Transgenic Drosophila As a Model of Parkinson's Disease and Related Synucleinopathies
por: Mizuno, Hideya, et al.
Publicado: (2010)

Roles of α-Synuclein and Disease-Associated Factors in Drosophila Models of Parkinson’s Disease
por: Suzuki, Mari, et al.
Publicado: (2022)

Intestine-derived α-synuclein initiates and aggravates pathogenesis of Parkinson’s disease in Drosophila
por: Liu, Wei, et al.
Publicado: (2022)

spargel, the PGC-1α homologue, in models of Parkinson disease in Drosophila melanogaster
por: Merzetti, Eric M., et al.
Publicado: (2015)

Adenosine A1 receptor ligands bind to α-synuclein: implications for α-synuclein misfolding and α-synucleinopathy in Parkinson’s disease
por: Jakova, Elisabet, et al.
Publicado: (2022)

Lipids: Key Players That Modulate α-Synuclein Toxicity and Neurodegeneration in Parkinson’s Disease
por: Mori, Akio, et al.
Publicado: (2020)

α-Synuclein Dimers Impair Vesicle Fission during Clathrin-Mediated Synaptic Vesicle Recycling
por: Medeiros, Audrey T., et al.
Publicado: (2017)

Voltage-Gated Calcium Channels and α-Synuclein: Implications in Parkinson’s Disease
por: Leandrou, Emmanouela, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_fe1pedags6f2coq6vud6qf48p7